收费全文 | 7063篇 |
免费 | 370篇 |
国内免费 | 79篇 |
耳鼻咽喉 | 165篇 |
儿科学 | 133篇 |
妇产科学 | 46篇 |
基础医学 | 800篇 |
口腔科学 | 138篇 |
临床医学 | 485篇 |
内科学 | 1887篇 |
皮肤病学 | 64篇 |
神经病学 | 520篇 |
特种医学 | 254篇 |
外科学 | 1446篇 |
综合类 | 35篇 |
一般理论 | 1篇 |
预防医学 | 262篇 |
眼科学 | 99篇 |
药学 | 274篇 |
中国医学 | 6篇 |
肿瘤学 | 897篇 |
2024年 | 6篇 |
2023年 | 54篇 |
2022年 | 87篇 |
2021年 | 156篇 |
2020年 | 95篇 |
2019年 | 129篇 |
2018年 | 186篇 |
2017年 | 141篇 |
2016年 | 209篇 |
2015年 | 206篇 |
2014年 | 281篇 |
2013年 | 298篇 |
2012年 | 481篇 |
2011年 | 526篇 |
2010年 | 335篇 |
2009年 | 276篇 |
2008年 | 429篇 |
2007年 | 472篇 |
2006年 | 490篇 |
2005年 | 476篇 |
2004年 | 452篇 |
2003年 | 407篇 |
2002年 | 343篇 |
2001年 | 75篇 |
2000年 | 65篇 |
1999年 | 76篇 |
1998年 | 102篇 |
1997年 | 57篇 |
1996年 | 67篇 |
1995年 | 56篇 |
1994年 | 45篇 |
1993年 | 49篇 |
1992年 | 51篇 |
1991年 | 32篇 |
1990年 | 40篇 |
1989年 | 30篇 |
1988年 | 29篇 |
1987年 | 21篇 |
1986年 | 24篇 |
1985年 | 13篇 |
1984年 | 20篇 |
1983年 | 17篇 |
1982年 | 13篇 |
1981年 | 8篇 |
1980年 | 21篇 |
1979年 | 9篇 |
1978年 | 7篇 |
1977年 | 6篇 |
1976年 | 8篇 |
1969年 | 7篇 |
Background
In 1999, the Japanese Orthopaedic Association decided to develop a new Cervical Myelopathy Evaluation Questionnaire (JOACMEQ). The final version of the JOACMEQ, comprising 24 questions and five domains (cervical spine function (CF); upper extremity function (UF); lower extremity function (LF); bladder function (BF); and quality of life (QOL)), was established after three nationwide investigations. The fourth investigation, reported in this paper, was performed to confirm the responsiveness of the questionnaire.Methods
A total of 137 patients with cervical myelopathy were included in the study. Each patient was interviewed twice using the JOACMEQ before and after treatment. At the second interview, the patients self-rated their condition in five domains for “worse,” “somewhat worse,” “no change,” “somewhat better,” or “better,” and these scores were defined as the external assessment rating. The difference of the points in five domains between the first and the second interview was calculated against each external assessment. Based on the results, substantial clinical benefit (SCB) thresholds for the JOACMEQ were determined.Results
The statistically significant median values of the acquired points were 17.5 for CF, 16.0 and 21.0 for UF, 27.0 and 20.5 for LF, 13.0 for BF, and 29.0 for QOL. After consideration of the results, the committee decided that an acquired point ≥20 could be interpreted as representing an SCB threshold for the JOACMEQ.Conclusion
We have concluded that a treatment can be judged to be effective for a patient if 1) The patient give all answers for the questions necessary to calculate the functional score of a domain and an increase of ≥20 points is obtained for that score, or 2) The functional score after treatment is > 90 points even if the answer for the unanswered questions was supposed to be the worst possible choice. 相似文献Patients who have undergone bariatric surgery are at risk for gallstone formation. However, the incidence of gallstone formation after bariatric surgery has not been adequately studied in the Japanese population. We aimed to elucidate the incidence and risk factors for gallstone formation after laparoscopic sleeve gastrectomy (LSG) for Japanese patients with severe obesity.
MethodsWe conducted a retrospective cohort study among patients with severe obesity treated with LSG between April 2017 and June 2020 at two institutions. Patients who had received previous cholecystectomy, had preoperative gallstones, and had received postoperative prophylactic ursodeoxycholic acid were excluded. Body weight, body mass index, and blood data were collected at each follow-up visit before and after the surgery. Follow-up abdominal ultrasonography was performed 6–12 months after surgery, and the incidence of gallstones was calculated. The association between the data and gallstone formation was evaluated.
ResultsDuring the study period, we performed LSG for 98 patients. Of these, 61 cases remained by above conditions and were examined using abdominal ultrasonography over 6 months after surgery. The incidence of gallstones was 23.0% and that of symptomatic gallstones was 3.3%. Anti-Helicobacter pylori antibody seropositive and titer were the only factors that showed significant association with de novo gallstone formation after LSG.
ConclusionsAnti-Helicobacter pylori antibody seropositive may be associated with de novo gallstone formation after LSG for Japanese patients with severe obesity.
Graphical abstract 相似文献